APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nimodipine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Nimodipine Market Outlook and Growth Opportunities 2026

21 December 2025194 pages

Choose your research edition.

Industry ResearchNimodipine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Nimodipine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Nimodipine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nimodipine Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Nimodipine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Nimodipine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nimodipine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Nimodipine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Nimodipine market include Yangtze River Pharmaceutical, Shandong Xinhua Pharmaceutical, Sichuan Kelun Pharmaceutical, Hubei Jumpcan Pharmaceutical, Jiangsu Hengrui Pharmaceuticals, Cisen Pharmaceutical, Bayer, Bionpharma and Azurity, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Nimodipine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Nimodipine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Nimodipine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Nimodipine market size, projected growth trends, production technologies, key applications, and end-use industries.

Nimodipine Segment by Company

Yangtze River Pharmaceutical

Shandong Xinhua Pharmaceutical

Sichuan Kelun Pharmaceutical

Hubei Jumpcan Pharmaceutical

Jiangsu Hengrui Pharmaceuticals

Cisen Pharmaceutical

Bayer

Bionpharma

Azurity

Avet Pharmaceuticals Inc.

Nimodipine Segment by Type

Solution

Tablets

Capsule

Nimodipine Segment by Application

Clinics

Hospital

Pharmacy

Others

Nimodipine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Nimodipine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Nimodipine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Nimodipine significant trends, drivers, influence factors in global and regions.

6. To analyze Nimodipine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nimodipine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nimodipine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nimodipine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Nimodipine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Nimodipine industry.

Chapter 3: Detailed analysis of Nimodipine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Nimodipine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Nimodipine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Nimodipine Industry Trends Table 2. Nimodipine Industry Drivers Table 3. Nimodipine Industry Opportunities and Challenges Table 4. Nimodipine Industry Restraints Table 5. Global Nimodipine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Nimodipine Revenue Share by Company (2021-2026) Table 7. Global Nimodipine Sales Volume by Company (tons) & (2021-2026) Table 8. Global Nimodipine Sales Volume Share by Company (2021-2026) Table 9. Global Nimodipine Average Price (US$/kg) of Company (2021-2026) Table 10. Global Nimodipine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Nimodipine Key Company Manufacturing Base & Headquarters Table 12. Global Nimodipine Company, Product Type & Application Table 13. Global Nimodipine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Nimodipine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Solution Table 18. Significant Companies of Tablets Table 19. Significant Companies of Capsule Table 20. Global Nimodipine Sales Volume by Type 2021 VS 2025 VS 2032 (tons) Table 21. Global Nimodipine Sales Volume by Type (2021-2026) & (tons) Table 22. Global Nimodipine Sales Volume by Type (2027-2032) & (tons) Table 23. Global Nimodipine Sales Volume Share by Type (2021-2026) Table 24. Global Nimodipine Sales Volume Share by Type (2027-2032) Table 25. Global Nimodipine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Nimodipine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Nimodipine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Nimodipine Sales Value Share by Type (2021-2026) Table 29. Global Nimodipine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Clinics Table 31. Significant Companies of Hospital Table 32. Significant Companies of Pharmacy Table 33. Significant Companies of Others Table 34. Global Nimodipine Sales Volume by Application 2021 VS 2025 VS 2032 (tons) Table 35. Global Nimodipine Sales Volume by Application (2021-2026) & (tons) Table 36. Global Nimodipine Sales Volume by Application (2027-2032) & (tons) Table 37. Global Nimodipine Sales Volume Share by Application (2021-2026) Table 38. Global Nimodipine Sales Volume Share by Application (2027-2032) Table 39. Global Nimodipine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Nimodipine Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Nimodipine Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Nimodipine Sales Value Share by Application (2021-2026) Table 43. Global Nimodipine Sales Value Share by Application (2027-2032) Table 44. Global Nimodipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Table 45. Global Nimodipine Sales by Region (2021-2026) & (tons) Table 46. Global Nimodipine Sales Market Share by Region (2021-2026) Table 47. Global Nimodipine Sales by Region (2027-2032) & (tons) Table 48. Global Nimodipine Sales Market Share by Region (2027-2032) Table 49. Global Nimodipine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Nimodipine Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Nimodipine Sales Value Share by Region (2021-2026) Table 52. Global Nimodipine Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Nimodipine Sales Value Share by Region (2027-2032) Table 54. Global Nimodipine Market Average Price (US$/kg) by Region (2021-2026) Table 55. Global Nimodipine Market Average Price (US$/kg) by Region (2027-2032) Table 56. Global Nimodipine Sales by Country: 2021 VS 2025 VS 2032 (tons) Table 57. Global Nimodipine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Nimodipine Sales by Country (2021-2026) & (tons) Table 59. Global Nimodipine Sales Market Share by Country (2021-2026) Table 60. Global Nimodipine Sales by Country (2027-2032) & (tons) Table 61. Global Nimodipine Sales Market Share by Country (2027-2032) Table 62. Global Nimodipine Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Nimodipine Sales Value Market Share by Country (2021-2026) Table 64. Global Nimodipine Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Nimodipine Sales Value Market Share by Country (2027-2032) Table 66. Yangtze River Pharmaceutical Company Information Table 67. Yangtze River Pharmaceutical Business Overview Table 68. Yangtze River Pharmaceutical Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 69. Yangtze River Pharmaceutical Nimodipine Product Portfolio Table 70. Yangtze River Pharmaceutical Recent Development Table 71. Shandong Xinhua Pharmaceutical Company Information Table 72. Shandong Xinhua Pharmaceutical Business Overview Table 73. Shandong Xinhua Pharmaceutical Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 74. Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio Table 75. Shandong Xinhua Pharmaceutical Recent Development Table 76. Sichuan Kelun Pharmaceutical Company Information Table 77. Sichuan Kelun Pharmaceutical Business Overview Table 78. Sichuan Kelun Pharmaceutical Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 79. Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio Table 80. Sichuan Kelun Pharmaceutical Recent Development Table 81. Hubei Jumpcan Pharmaceutical Company Information Table 82. Hubei Jumpcan Pharmaceutical Business Overview Table 83. Hubei Jumpcan Pharmaceutical Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 84. Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio Table 85. Hubei Jumpcan Pharmaceutical Recent Development Table 86. Jiangsu Hengrui Pharmaceuticals Company Information Table 87. Jiangsu Hengrui Pharmaceuticals Business Overview Table 88. Jiangsu Hengrui Pharmaceuticals Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 89. Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio Table 90. Jiangsu Hengrui Pharmaceuticals Recent Development Table 91. Cisen Pharmaceutical Company Information Table 92. Cisen Pharmaceutical Business Overview Table 93. Cisen Pharmaceutical Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 94. Cisen Pharmaceutical Nimodipine Product Portfolio Table 95. Cisen Pharmaceutical Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 99. Bayer Nimodipine Product Portfolio Table 100. Bayer Recent Development Table 101. Bionpharma Company Information Table 102. Bionpharma Business Overview Table 103. Bionpharma Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 104. Bionpharma Nimodipine Product Portfolio Table 105. Bionpharma Recent Development Table 106. Azurity Company Information Table 107. Azurity Business Overview Table 108. Azurity Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 109. Azurity Nimodipine Product Portfolio Table 110. Azurity Recent Development Table 111. Avet Pharmaceuticals Inc. Company Information Table 112. Avet Pharmaceuticals Inc. Business Overview Table 113. Avet Pharmaceuticals Inc. Nimodipine Sales (tons), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 114. Avet Pharmaceuticals Inc. Nimodipine Product Portfolio Table 115. Avet Pharmaceuticals Inc. Recent Development Table 116. Key Raw Materials Table 117. Raw Materials Key Suppliers Table 118. Nimodipine Distributors List Table 119. Nimodipine Customers List Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Nimodipine Product Image Figure 2. Global Nimodipine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Nimodipine Sales (2021-2032) & (tons) Figure 5. Global Nimodipine Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Nimodipine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Solution Image Figure 10. Tablets Image Figure 11. Capsule Image Figure 12. Global Nimodipine Sales Volume by Type (2021 VS 2025 VS 2032) & (tons) Figure 13. Global Nimodipine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Nimodipine Sales Volume Share by Type (2021-2032) Figure 15. Global Nimodipine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Nimodipine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Nimodipine Sales Value Share by Type (2021-2032) Figure 18. Clinics Image Figure 19. Hospital Image Figure 20. Pharmacy Image Figure 21. Others Image Figure 22. Global Nimodipine Sales Volume by Application (2021 VS 2025 VS 2032) & (tons) Figure 23. Global Nimodipine Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Nimodipine Sales Volume Share by Application (2021-2032) Figure 25. Global Nimodipine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Nimodipine Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Nimodipine Sales Value Share by Application (2021-2032) Figure 28. Global Nimodipine Sales by Region: 2021 VS 2025 VS 2032 (tons) Figure 29. Global Nimodipine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Nimodipine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Nimodipine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 33. North America Nimodipine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Nimodipine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Nimodipine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 39. South America Nimodipine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Nimodipine Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Nimodipine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Nimodipine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Nimodipine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Nimodipine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Nimodipine Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Nimodipine Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Solution
  • Tablets
  • Capsule
Applications
  • Clinics
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Yangtze River Pharmaceutical
  • Shandong Xinhua Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Hubei Jumpcan Pharmaceutical
  • Jiangsu Hengrui Pharmaceuticals
  • Cisen Pharmaceutical
  • Bayer
  • Bionpharma
  • Azurity
  • Avet Pharmaceuticals Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nimodipine Sales Value (2021-2032)
  4. 1.2.2 Global Nimodipine Sales Volume (2021-2032)
  5. 1.2.3 Global Nimodipine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Nimodipine Market Dynamics
  1. 2.1 Nimodipine Industry Trends
  2. 2.2 Nimodipine Industry Drivers
  3. 2.3 Nimodipine Industry Opportunities and Challenges
  4. 2.4 Nimodipine Industry Restraints
3 Nimodipine Market by Company
  1. 3.1 Global Nimodipine Company Revenue Ranking in 2025
  2. 3.2 Global Nimodipine Revenue by Company (2021-2026)
  3. 3.3 Global Nimodipine Sales Volume by Company (2021-2026)
  4. 3.4 Global Nimodipine Average Price by Company (2021-2026)
  5. 3.5 Global Nimodipine Company Ranking (2024-2026)
  6. 3.6 Global Nimodipine Company Manufacturing Base and Headquarters
  7. 3.7 Global Nimodipine Company Product Type and Application
  8. 3.8 Global Nimodipine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Nimodipine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Nimodipine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Nimodipine Market by Type
  1. 4.1 Nimodipine Type Introduction
  2. 4.1.1 Solution
  3. 4.1.2 Tablets
  4. 4.1.3 Capsule
  5. 4.2 Global Nimodipine Sales Volume by Type
  6. 4.2.1 Global Nimodipine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Nimodipine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Nimodipine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Nimodipine Sales Value by Type
  10. 4.3.1 Global Nimodipine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Nimodipine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Nimodipine Sales Value Share by Type (2021-2032)
5 Nimodipine Market by Application
  1. 5.1 Nimodipine Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Pharmacy
  5. 5.1.4 Others
  6. 5.2 Global Nimodipine Sales Volume by Application
  7. 5.2.1 Global Nimodipine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Nimodipine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Nimodipine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Nimodipine Sales Value by Application
  11. 5.3.1 Global Nimodipine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Nimodipine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Nimodipine Sales Value Share by Application (2021-2032)
6 Nimodipine Regional Sales and Value Analysis
  1. 6.1 Global Nimodipine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Nimodipine Sales by Region (2021-2032)
  3. 6.2.1 Global Nimodipine Sales by Region: 2021-2026
  4. 6.2.2 Global Nimodipine Sales by Region (2027-2032)
  5. 6.3 Global Nimodipine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Nimodipine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Nimodipine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Nimodipine Sales Value by Region (2027-2032)
  9. 6.5 Global Nimodipine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Nimodipine Sales Value (2021-2032)
  12. 6.6.2 North America Nimodipine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Nimodipine Sales Value (2021-2032)
  15. 6.7.2 Europe Nimodipine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Nimodipine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Nimodipine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Nimodipine Sales Value (2021-2032)
  21. 6.9.2 South America Nimodipine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Nimodipine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Nimodipine Sales Value Share by Country, 2025 VS 2032
7 Nimodipine Country-level Sales and Value Analysis
  1. 7.1 Global Nimodipine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Nimodipine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Nimodipine Sales by Country (2021-2032)
  4. 7.3.1 Global Nimodipine Sales by Country (2021-2026)
  5. 7.3.2 Global Nimodipine Sales by Country (2027-2032)
  6. 7.4 Global Nimodipine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Nimodipine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Nimodipine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Nimodipine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Nimodipine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Nimodipine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Nimodipine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Nimodipine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Nimodipine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Nimodipine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Nimodipine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Nimodipine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Nimodipine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Nimodipine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Nimodipine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Nimodipine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Nimodipine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Nimodipine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Nimodipine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Nimodipine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Nimodipine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Nimodipine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Nimodipine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Nimodipine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Nimodipine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Nimodipine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Nimodipine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Nimodipine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Nimodipine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Nimodipine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Nimodipine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Nimodipine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Nimodipine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Nimodipine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Nimodipine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Nimodipine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Nimodipine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Nimodipine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Nimodipine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Nimodipine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Nimodipine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Nimodipine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Nimodipine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Nimodipine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Nimodipine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Nimodipine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Nimodipine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Nimodipine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Nimodipine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Nimodipine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Nimodipine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Nimodipine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Nimodipine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Nimodipine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Nimodipine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Nimodipine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Nimodipine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Nimodipine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Nimodipine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Nimodipine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Nimodipine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Nimodipine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Nimodipine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Nimodipine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Nimodipine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Nimodipine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Nimodipine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Nimodipine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Nimodipine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Nimodipine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Nimodipine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Nimodipine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Nimodipine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Nimodipine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Nimodipine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Nimodipine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Nimodipine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Nimodipine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Nimodipine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Nimodipine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Nimodipine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Nimodipine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Nimodipine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Nimodipine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Nimodipine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Nimodipine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Nimodipine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yangtze River Pharmaceutical
  2. 8.1.1 Yangtze River Pharmaceutical Company Information
  3. 8.1.2 Yangtze River Pharmaceutical Business Overview
  4. 8.1.3 Yangtze River Pharmaceutical Nimodipine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yangtze River Pharmaceutical Nimodipine Product Portfolio
  6. 8.1.5 Yangtze River Pharmaceutical Recent Developments
  7. 8.2 Shandong Xinhua Pharmaceutical
  8. 8.2.1 Shandong Xinhua Pharmaceutical Company Information
  9. 8.2.2 Shandong Xinhua Pharmaceutical Business Overview
  10. 8.2.3 Shandong Xinhua Pharmaceutical Nimodipine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shandong Xinhua Pharmaceutical Nimodipine Product Portfolio
  12. 8.2.5 Shandong Xinhua Pharmaceutical Recent Developments
  13. 8.3 Sichuan Kelun Pharmaceutical
  14. 8.3.1 Sichuan Kelun Pharmaceutical Company Information
  15. 8.3.2 Sichuan Kelun Pharmaceutical Business Overview
  16. 8.3.3 Sichuan Kelun Pharmaceutical Nimodipine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sichuan Kelun Pharmaceutical Nimodipine Product Portfolio
  18. 8.3.5 Sichuan Kelun Pharmaceutical Recent Developments
  19. 8.4 Hubei Jumpcan Pharmaceutical
  20. 8.4.1 Hubei Jumpcan Pharmaceutical Company Information
  21. 8.4.2 Hubei Jumpcan Pharmaceutical Business Overview
  22. 8.4.3 Hubei Jumpcan Pharmaceutical Nimodipine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hubei Jumpcan Pharmaceutical Nimodipine Product Portfolio
  24. 8.4.5 Hubei Jumpcan Pharmaceutical Recent Developments
  25. 8.5 Jiangsu Hengrui Pharmaceuticals
  26. 8.5.1 Jiangsu Hengrui Pharmaceuticals Company Information
  27. 8.5.2 Jiangsu Hengrui Pharmaceuticals Business Overview
  28. 8.5.3 Jiangsu Hengrui Pharmaceuticals Nimodipine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Hengrui Pharmaceuticals Nimodipine Product Portfolio
  30. 8.5.5 Jiangsu Hengrui Pharmaceuticals Recent Developments
  31. 8.6 Cisen Pharmaceutical
  32. 8.6.1 Cisen Pharmaceutical Company Information
  33. 8.6.2 Cisen Pharmaceutical Business Overview
  34. 8.6.3 Cisen Pharmaceutical Nimodipine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Cisen Pharmaceutical Nimodipine Product Portfolio
  36. 8.6.5 Cisen Pharmaceutical Recent Developments
  37. 8.7 Bayer
  38. 8.7.1 Bayer Company Information
  39. 8.7.2 Bayer Business Overview
  40. 8.7.3 Bayer Nimodipine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Bayer Nimodipine Product Portfolio
  42. 8.7.5 Bayer Recent Developments
  43. 8.8 Bionpharma
  44. 8.8.1 Bionpharma Company Information
  45. 8.8.2 Bionpharma Business Overview
  46. 8.8.3 Bionpharma Nimodipine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Bionpharma Nimodipine Product Portfolio
  48. 8.8.5 Bionpharma Recent Developments
  49. 8.9 Azurity
  50. 8.9.1 Azurity Company Information
  51. 8.9.2 Azurity Business Overview
  52. 8.9.3 Azurity Nimodipine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Azurity Nimodipine Product Portfolio
  54. 8.9.5 Azurity Recent Developments
  55. 8.10 Avet Pharmaceuticals Inc.
  56. 8.10.1 Avet Pharmaceuticals Inc. Company Information
  57. 8.10.2 Avet Pharmaceuticals Inc. Business Overview
  58. 8.10.3 Avet Pharmaceuticals Inc. Nimodipine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Avet Pharmaceuticals Inc. Nimodipine Product Portfolio
  60. 8.10.5 Avet Pharmaceuticals Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Nimodipine Value Chain Analysis
  2. 9.1.1 Nimodipine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Nimodipine Sales Mode & Process
  6. 9.2 Nimodipine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Nimodipine Distributors
  9. 9.2.3 Nimodipine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst